ArticleBMC medical research methodology2025
Semiautomatic mapping of a national drug terminology to standardised OMOP drug concepts using publicly available supplementary information.
Article in BMC medical research methodology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Real-World Use of Controlled Terminologies, Ontologies, and Vocabularies for Evidence Generation Across a Large International Observational Network: Challenges and Lessons Learned From a Mixed Method Study.JMIR medical informatics · 2026Article
- SafeRx: A Canonical Pharmaceutical Knowledge Integration Framework for Multimodal Medication Safety.Bioengineering (Basel, Switzerland) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundMapping national drug terminologies to internationally recognized standards is essential for harmonising health data across regions and supporting secondary data use. In Austria, the national drug terminology lacks fine-granular mappings to RxNorm and RxNorm Extension (RxN/E), limiting its integration into the Observational Medical Outcomes Partnership (OMOP) Common Data Model (CDM). This study aims to semiautomatically map Austria's national drug terminology to RxN/E, to enable improved interoperability and data standardisation for secondary use.
methodsWe implemented a semiautomated mapping approach using public supplementary data to bridge the gap between national drug concepts and RxN/E concepts. Probabilistic matching and hierarchical refinement techniques were applied to derive finer-grained and more meaningful mappings than previously available ingredient level mappings via the Anatomical Therapeutic Chemical (ATC) classification. We linked our mappings to other available European drug mappings for a validation of our results.
resultsOur process successfully mapped 18,390 (95.42%) of Austria's 19,273 drug concepts to RxN/E, surpassing previous mappings that focused solely on ingredient-level relationships. Specifically, we mapped 73.65% of the concepts to more specific RxN/E targets, such as branded drug boxes and quantified clinical drugs. We identified multiple vocabulary inconsistencies, including duplications and erroneous relationships within RxN/E, which were documented for improvement. The results are disseminated as Usagi-formatted CSV files and HL7 FHIR ConceptMaps to encourage transparency, ease of use, and community-driven refinement.
conclusionsThe presented mapping approach highlights the feasibility and utility of leveraging publicly available supplementary data to create mappings between national drug terminology and RxN/E. Our method yields fine-grained mappings, enabling precise and comprehensive drug data integration for secondary use.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.